{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:27:02Z","timestamp":1790332022627,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2314,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Cholangiocarcinomas (CCAs) are aggressive cancers, with high mortality and poor survival rates. Only radical surgery offers patients some hope of cure; however, most patients are not surgical candidates because of late diagnosis secondary to relatively poor accuracy of diagnostic means. MicroRNAs (miRs) are involved in every cancer examined, but they have not been evaluated in primary CCA. In this study, miR arrays were performed on five primary CCAs and five normal bile duct specimens (NBDs). Several miRs were dysregulated and miR-21 was overexpressed in CCAs. miR-21 differential expression in these 10 specimens was verified by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). To validate these findings, qRT-PCR for miR-21 was then performed on 18 additional primary CCAs and 12 normal liver specimens. MiR-21 was 95% sensitive and 100% specific in distinguishing between CCA and normal tissues, with an area under the receiver operating characteristic curve of 0.995. Inhibitors of miR-21 increased protein levels of programmed cell death 4 (PDCD4) and tissue inhibitor of metalloproteinases 3 (TIMP3). Notably, messenger RNA levels of TIMP3 were significantly lower in CCAs than in normals.\n                      <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic>\n                      MiR-21 is overexpressed in human CCAs. Furthermore, miR-21 may be oncogenic, at least in part, by inhibiting PDCD4 and TIMP3. Finally, these data suggest that TIMP3 is a candidate tumor suppressor gene in the biliary tree. (Hepatology 2009.)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22838","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T17:23:39Z","timestamp":1233768219000},"page":"1595-1601","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":227,"title":["MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 #"],"prefix":"10.1097","volume":"49","author":[{"given":"Florin M.","family":"Selaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru V.","family":"Olaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsugu","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Paun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Georgiades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perumal","family":"Vivekanandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Torbenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Hruban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20241201","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers.","volume":"341","author":"de Groen","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-22-20241201","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.","volume":"48","author":"Blechacz","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R3-22-20241201","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma.","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"R4-22-20241201","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.","volume":"33","author":"Patel","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R5-22-20241201","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4065\/70.5.425","article-title":"Natural history of unresected cholangiocarcinoma: patient outcome after noncurative intervention.","volume":"70","author":"Farley","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"R6-22-20241201","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ncpgasthep0389","article-title":"Cholangiocarcinoma.","volume":"3","author":"Patel","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R7-22-20241201","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2004-828895","article-title":"Surgical management of cholangiocarcinoma.","volume":"24","author":"Jarnagin","year":"2004","journal-title":"Semin Liver Dis"},{"key":"R8-22-20241201","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2006.09.001","article-title":"Cholangiocarcinoma: modern advances in understanding a deadly old disease.","volume":"45","author":"Malhi","year":"2006","journal-title":"J Hepatol"},{"key":"R9-22-20241201","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1038\/sj.onc.1209914","article-title":"Implications of microRNA profiling for cancer diagnosis.","volume":"25","author":"Cummins","year":"2006","journal-title":"Oncogene"},{"key":"R10-22-20241201","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","article-title":"miRNAs, cancer, and stem cell division.","volume":"122","author":"Croce","year":"2005","journal-title":"Cell"},{"key":"R11-22-20241201","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","article-title":"Involvement of human microRNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.","volume":"130","author":"Meng","year":"2006","journal-title":"Gastroenterology"},{"key":"R12-22-20241201","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.onc.1210648","article-title":"Epigenetic regulation of microRNA370 by interleukin6 in malignant human cholangiocytes.","volume":"27","author":"Meng","year":"2008","journal-title":"Oncogene"},{"key":"R13-22-20241201","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1158\/1535-7163.MCT-05-0103","article-title":"Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers.","volume":"4","author":"Karikari","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"R14-22-20241201","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1620\/tjem.177.61","article-title":"Establishment of a new extrahepatic bile duct carcinoma cell line, TFK1.","volume":"177","author":"Saijyo","year":"1995","journal-title":"Tohoku J Exp Med"},{"key":"R15-22-20241201","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccr.2008.02.013","article-title":"E2F1regulated microRNAs impair TGFbetadependent cellcycle arrest and apoptosis in gastric cancer.","volume":"13","author":"Petrocca","year":"2008","journal-title":"Cancer Cell"},{"key":"R16-22-20241201","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/hep.22158","article-title":"MicroRNA gene expression profile of hepatitis C virusassociated hepatocellular carcinoma.","volume":"47","author":"Varnholt","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R17-22-20241201","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/hep.22256","article-title":"MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogenetumor suppressor gene mutations.","volume":"47","author":"Ladeiro","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R18-22-20241201","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"R19-22-20241201","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1038\/sj.onc.1209634","article-title":"Involvement of programmed cell death 4 in transforming growth factorbeta1induced apoptosis in human hepatocellular carcinoma.","volume":"25","author":"Zhang","year":"2006","journal-title":"Oncogene"},{"key":"R20-22-20241201","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1038\/onc.2008.72","article-title":"MicroRNA21 promotes cell transformation by targeting the programmed cell death 4 gene.","volume":"27","author":"Lu","year":"2008","journal-title":"Oncogene"},{"key":"R21-22-20241201","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-9440(10)64262-9","article-title":"Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.","volume":"161","author":"Lee","year":"2002","journal-title":"Am J Pathol"},{"key":"R22-22-20241201","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1158\/1078-0432.CCR-06-0921","article-title":"Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.","volume":"12","author":"Yuan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R23-22-20241201","first-page":"487","article-title":"TIMP3 gene transfection suppresses invasive and metastatic capacity of human hepatocarcinoma cell line HCC7721.","volume":"6","author":"Zhang","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R24-22-20241201","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/MCB.00479-08","article-title":"MiR21 promotes glioma invasion by targeting MMP regulators.","volume":"28","author":"Gabriely","year":"2008","journal-title":"Mol Cell Biol"},{"key":"R25-22-20241201","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","article-title":"mir29 regulates Mcl1 protein expression and apoptosis.","volume":"26","author":"Mott","year":"2007","journal-title":"Oncogene"},{"key":"R26-22-20241201","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2353\/ajpath.2008.080096","article-title":"Elevated expression of the miR1792 polycistron and miR21 in hepadnavirusassociated hepatocellular carcinoma contributes to the malignant phenotype.","volume":"173","author":"Connolly","year":"2008","journal-title":"Am J Pathol"},{"key":"R27-22-20241201","first-page":"907","article-title":"miR21 microRNA expression in human gastric carcinomas and its clinical association.","volume":"28","author":"Chan","year":"2008","journal-title":"Anticancer Res"},{"key":"R28-22-20241201","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000113489","article-title":"Altered expression of miR21, miR31, miR143 and miR145 is related to clinicopathologic features of colorectal cancer.","volume":"72","author":"Slaby","year":"2007","journal-title":"Oncology"},{"key":"R29-22-20241201","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11605-008-0584-x","article-title":"MicroRNA21 is overexpressed in pancreatic cancer and a potential predictor of survival.","volume":"12","author":"Dillhoff","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R30-22-20241201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.biolcel.2003.09.003","article-title":"Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?","volume":"95","author":"LankatButtgereit","year":"2003","journal-title":"Biol Cell"},{"key":"R31-22-20241201","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-1119(95)00607-9","article-title":"Isolation of a novel mouse gene MA3 that is induced upon programmed cell death.","volume":"166","author":"Shibahara","year":"1995","journal-title":"Gene"},{"key":"R32-22-20241201","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2008.24","article-title":"MicroRNA21 targets tumor suppressor genes in invasion and metastasis.","volume":"18","author":"Zhu","year":"2008","journal-title":"Cell Res"},{"key":"R33-22-20241201","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1074\/jbc.M707224200","article-title":"Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR21 in breast cancer cells.","volume":"283","author":"Frankel","year":"2008","journal-title":"J Biol Chem"},{"key":"R34-22-20241201","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA21 (miR21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"key":"R35-22-20241201","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/sj.onc.1205291","article-title":"Complex roles of tissue inhibitors of metalloproteinases in cancer.","volume":"21","author":"Jiang","year":"2002","journal-title":"Oncogene"},{"key":"R36-22-20241201","first-page":"5723","article-title":"Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases2 into the liver tissue.","volume":"60","author":"Brand","year":"2000","journal-title":"Cancer Res"},{"key":"R37-22-20241201","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4615-5357-1_11","article-title":"High level expression of tissue inhibitors of metalloproteinases1, 2, and 3 in melanoma cells achieved by adenovirus mediated gene transfer.","volume":"451","author":"Ahonen","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R38-22-20241201","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1158\/0008-5472.CAN-07-2734","article-title":"Tissue inhibitor of metalloproteinase3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.","volume":"68","author":"Mahller","year":"2008","journal-title":"Cancer Res"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22838","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/01515467-200905000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:40:40Z","timestamp":1786038040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01515467-200905000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22838","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1165562.628572","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}